五礦地產(00230.HK)2020年全口徑簽約銷售額升124.0%至193.6億元
格隆匯1月18日丨五礦地產(00230.HK)公佈,公司連同其附屬公司、合營公司及聯營公司的2020年全年簽約銷售額約193.6億元人民幣,相應簽約銷售面積約75.3萬平方米,銷售均價約為每平方米2.57萬元人民幣。公司2020年全年簽約銷售額及簽約銷售面積,分別按年上升約124.0%及約69.1%。
公司2020年簽約銷售額攀升至歷史高位的主要原因,在於公司年內從控股股東所收購的房地產發展項目的簽約銷售金額自2020年9月起計入公司的銷售額,以及公司於大灣區的廣州、深圳及香港等地的多個新項目於2020年下半年進入銷售階段所致。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.